Hwang Gyu Ho, Joo Jae Woo, Song In Sik, Rah Yoon Chan, Choi June
Department of Otorhinolaryngology, Head and Neck surgery, Korea University College of Medicine, Seoul, Republic of Korea.
J Int Adv Otol. 2017 Aug;13(2):211-216. doi: 10.5152/iao.2017.2867.
In this study, we evaluated the prognostic value of the Dizziness Handicap Inventory (DHI) and the Tinnitus Handicap Inventory (THI) in patients with unilateral sudden sensorineural hearing loss (SSNHL).
In total, 101 patients with unilateral SSNHL (44 women, 57 men), who were admitted and treated at our institution between December 2012 and June 2014, were included in the study. All patients completed the questionnaires for DHI and THI during their admission and were treated with bed rest and oral methylprednisolone (1 mg/kg, which was eventually tapered). Of these, 83 patients received intratympanic dexamethasone 4 times over a 2-week period. Demographic data, accompanying symptoms, and DHI and THI subscales were compared between the non-recovery group (Siegel's criteria type 4, n=63) and the recovery group (Siegel's criteria type 1-3, n=38).
There were no significant differences between the two groups with regard to gender, hypertension, diabetes mellitus, cerebrovascular attack, and tinnitus. Patients in the non-recovery group were significantly older (51.53 vs. 50.24 years, p<0.05) and had a higher incidence of chronic kidney disease (10.53% vs. 1.59%, p<0.05) than those in the recovery group. Although more patients in the non-recovery group complained of dizziness (47.37% vs. 25.40%, p<0.05), DHI subscales were not significantly different between the groups. THI subscales were also not significantly different between the two groups.
DHI and THI questionnaires may have limited prognostic value for patients with unilateral SSNHL.
在本研究中，我们评估了眩晕 handicap 量表（DHI）和耳鸣 handicap 量表（THI）对单侧突发性感音神经性听力损失（SSNHL）患者的预后价值。
本研究纳入了 2012 年 12 月至 2014 年 6 月期间在我院收治并接受治疗的 101 例单侧 SSNHL 患者（44 例女性，57 例男性）。所有患者在入院期间均完成了 DHI 和 THI 问卷，并接受了卧床休息和口服甲泼尼龙治疗（1mg/kg，最终逐渐减量）。其中，83 例患者在 2 周内接受了 4 次鼓室内注射地塞米松。比较了未恢复组（Siegel 标准 4 型，n = 63）和恢复组（Siegel 标准 1 - 3 型，n = 38）之间的人口统计学数据、伴随症状以及 DHI 和 THI 子量表。
两组在性别、高血压、糖尿病、脑血管意外和耳鸣方面无显著差异。未恢复组患者的年龄显著大于恢复组（51.53 岁 vs. 50.24 岁，p < 0.05），慢性肾脏病的发生率也高于恢复组（10.53% vs. 1.59%，p < 0.05）。虽然未恢复组中抱怨眩晕的患者更多（47.37% vs. 25.40%，p < 0.05），但两组之间的 DHI 子量表无显著差异。两组之间的 THI 子量表也无显著差异。
DHI 和 THI 问卷对单侧 SSNHL 患者的预后价值可能有限。
